Status:

COMPLETED

Internal Iliac Artery Ligation Before Cesarean Hysterectomy in Morbidly Adherent Placenta

Lead Sponsor:

Ain Shams University

Conditions:

Blood Loss

Eligibility:

FEMALE

25-40 years

Phase:

PHASE3

Brief Summary

40 pregnant females at term diagnosed with morbidly adherent placenta and planned for elective cesarean section were recruited and randomized to 2 groups. Group A: Internal iliac ligation followed by ...

Eligibility Criteria

Inclusion

  • Placenta previa accreta
  • Previous 2 cesarean section
  • completed her family
  • Hemoglobin \> 11 gm/dl
  • Elective cesarean hysterectomy

Exclusion

  • Anemia ( Hemoglobin \< 11 gm/dl)
  • Not completed her family
  • BMI \> 35 Kg/m2
  • Bleeding tendency
  • Emergengy cesarean section
  • Thrombophilia

Key Trial Info

Start Date :

March 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 2 2020

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT03824873

Start Date

March 1 2017

End Date

July 2 2020

Last Update

July 8 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ain Shams University Maternity Hospital

Cairo, Egypt

Internal Iliac Artery Ligation Before Cesarean Hysterectomy in Morbidly Adherent Placenta | DecenTrialz